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ABSTRACT
Expression of dsRNA complementary to small nu-
cleolar RNAs (snoRNAs) in Trypanosoma brucei
results in snoRNA silencing, termed snoRNAi.
Here, we demonstrate that snoRNAi requires the
nuclear TbDCL2 protein, but not TbDCL1, which is
involved in RNA interference (RNAi) in the cyto-
plasm. snoRNAi depends on Argonaute1 (Slicer),
and on TbDCL2, suggesting that snoRNA dicing
and slicing takes place in the nucleus, and further
suggesting that AGO1 is active in nuclear silencing.
snoRNAi was next utilized to elucidate the function
of an abundant snoRNA, TB11Cs2C2 (92nt), present
in a cluster together with the spliced leader
associated RNA (SLA1) and snR30, which are both
H/ACA RNAs with special nuclear functions. Using
AMT-UV cross-linking and RNaseH cleavage, we
provide evidence for the interaction of TB11Cs2C2
with the small rRNAs, srRNA-2 and srRNA-6, which
are part of the large subunit (LSU) rRNA. snoRNAi of
TB11Cs2C2 resulted in defects in generating
srRNA-2 and LSUb rRNA. This is the first snoRNA
described so far to engage in trypanosome-specific
processing events.
INTRODUCTION
RNA interference (RNAi) in Trypanosoma brucei was one
of the ﬁrst dsRNA-mediated silencing systems described in
eukaryotes (1); since its discovery, RNAi has become one
of the most useful tools for elucidating the function of
protein coding genes in these organisms. In T. brucei,
the natural RNAi pathway down-regulates transcripts
from the retroposons, SLACS and INGI (2–4), and
from a family of 147bp chromosomal internal repeats,
termed CIR 147 (5), which are present in a subset of
putative centromeric regions (6). The nature of the
target transcripts suggests that one major function of
RNAi in T. brucei is to promote genome stability,
though RNAi may also have a role in chromosome segre-
gation (2,7,8).
The ‘classical’ RNAi pathway, which is triggered by
long dsRNA, is mediated by two key enzymes, Dicer, an
enzyme of the RNase III family, and Slicer, a member of
the Argonaute (AGO) protein family with an RNase
H-type fold (9). Trypanosomes, like yeast, possess a
single Argonaute (AGO1) homolog (2,10), but, unlike
yeast, express two Dicer-like (DCL) proteins, TbDCL1
(3) and TbDCL2 (3,5). TbDCL1 is cytoplasmic and
mediates the cytoplasmic RNAi response, which is har-
nessed in experimental RNAi to induce mRNA degrad-
ation. In contrast, TbDCL2, which is mostly nuclear (5), is
central for dicing both retroposon and repeat-derived
dsRNA and provides the ﬁrst line of defense against
these potentially dangerous molecules in the nucleus. On
the other hand, both TbDCL1 and TbDCL2 contribute to
the generation of retroposon-derived small interfering
RNAs (siRNAs), suggesting that the two DCL proteins
have both distinct and shared functions.
The existence of a nuclear phase of RNAi was also sug-
gested by our previous studies demonstrating
downregulation of small nucleolar RNAs (snoRNAs),
triggered by expression of anti-sense RNA from an
episomal vector in the monogenetic trypanosomatid,
Leptomonas collosoma. This process was termed
snoRNAi (11). We showed that snoRNAi in L. collosoma
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further provided evidence for the accumulation of siRNAs
in snoRNAi-silenced cells. In T. brucei snoRNAi was
achieved by expressing snoRNA information using a
tetracycline inducible vector equipped with opposing T7
RNA polymerase (pol) promoters (11). Since the discov-
ery of snoRNAi in trypanosomatids, the efﬁcient silencing
by siRNAs of telomerase RNA and 7SK RNA, two
nuclear small RNAs, was reported, suggesting that
nuclear RNAs can be down-regulated by RNAi in
mammals, as well (12).
snoRNAs are one of the most abundant families of non-
coding RNAs in eukaryotic genomes. Eukaryotic rRNA
undergo both processing and extensive covalent modiﬁca-
tion that require the function of snoRNAs (13–16). The
modiﬁcations include methylation of the 20-hydroxyl
residue (20-O-methylation, Nm) (17) and isomerization
of the uracil to pseudouridine (18,19). The snoRNAs
guide these modiﬁcations following site-speciﬁc
base-pairing with their targets. The snoRNAs that guide
these modiﬁcations are designated by their speciﬁc
sequence motifs: C/D boxed RNAs guide Nm, and
H/ACA RNAs guide pseudouridylation (17–19). The
C/D box RNAs, which are most relevant for this study,
have 10–22nt sequences of perfect complementarity to the
sequences within the mature rRNA (20).
Recent genomic and functional studies revealed a very
rich repertoire of snoRNAs in trypanosomes. Initial
studies identiﬁed 21 clusters encoding 57C/D snoRNAs
and 34H/ACA-like RNAs (21). Additional C/D
snoRNAs were identiﬁed after partially mapping Nms
on rRNA (22). An algorithm designed to identify the tryp-
anosome single hairpin H/ACA-like RNA species carrying
an AGA box at the 30-end, identiﬁed additional H/ACA
RNAs in T. brucei (23). At present, 46H/ACA have been
identiﬁed in T. brucei that have homologs in the other
trypanosomatid species (24).
rRNA processing in trypanosomes differs from matur-
ation in most eukaryotes. The small subunit (SSU) rRNA
in trypanosomes is the largest known so far, and the large
subunit (LSU) rRNA is processed into six fragments, two
large ones termed LSUa and LSUb rRNAs, and four
small fragments, termed the small rRNA (srRNA)
(25–27). The only trypanosome snoRNAs involved in
rRNA maturation identiﬁed to date are U3, snR30 and
MRP RNAs (22,28,29). Several of the snoRNAs shown to
function in rRNA processing in other eukaryotes,
including U22, U8, U14, have not been identiﬁed to
date in trypanosomes (20).
In this study, we examined the mechanism of snoRNAi
in T. brucei, and found that silencing of the TB11Cs2C2
snoRNA requires TbDCL2, since co-silencing of
TB11Cs2C2 and TbDCL2 nearly abolished snoRNAi.
No effect on snoRNAi was observed in cells expressing
a dominant negative TbDCL1 allele, previously shown to
inhibit the cytoplasmic RNAi response (3). snoRNAi was
also compromised in cells silenced for AGO1, suggesting
that the snoRNAi requires the function of both TbAGO1
and TbDCL2. snoRNAi was then used to investigate the
function of TB11Cs2C2 snoRNA, one of the most
abundant snoRNA forms in trypanosomes, and
previously implicated in methylation of LSU rRNA (30).
Here, we demonstrate the interaction between TB11Cs2C2
and its targets using in vivo UV-induced AMT
cross-linking. SnoRNAi of TB11Cs2C2 suggests that this
RNA is involved in rRNA processing of LSUb to release
the small rRNA fragments, srRNA-2 and -6. This is the
ﬁrst snoRNA described to date that mediates
trypanosome-speciﬁc rRNA processing events. The
function of the neighboring TB11CsC1 snoRNA was
also elucidated, and this snoRNA is implicated in process-
ing of SSU rRNA. This study suggests that snoRNAi
operates in the nucleus utilizing TbDCL2 and TbAGO1,
and this process can be harnessed to elucidate the function
of nuclear/nucleolar non-coding RNAs.
MATERIALS AND METHODS
All the oligonucleotides used in this study are listed in
Supplementary Figure S1.
Cell culture, constructs and transfection
Procyclic T. brucei strain 29–13 which carries integrated
genes for T7 polymerase and the tetracycline repressor was
grown in SDM-79 medium supplemented with 10% foetal
calf serum in the presence of 50mg/ml hygromycin and
15mg/ml G418. The T7 RNA pol opposing silencing con-
structs were prepared as previously described (31) using
oligonucleotides listed in Supplementary Data S1. Cells
were transfected and clonal populations were obtained
in microtiter plates, as previously described (32).
Northern blot analysis
Total RNA was prepared with TRI-Reagent (Sigma), and
20mg/lane were fractionated on a 1.2% agarose, 2.2M
formaldehyde gel. The RNA was visualized with
ethidium bromide. The TbDCL2 and SmD3 mRNAs
were detected using a randomly labeled probe (Random
Primer DNA Labeling Mix, Biological Industries Ltd.).
For analyzing snoRNAs and siRNAs, total RNA (10mg)
was fractionated on a 10% polyacrylamide gel containing
7M urea. The RNA was transferred to a nylon membrane
(Hybond; Amersham Biosciences), and probed with an
anti-sense RNA probe speciﬁc to the gene.
RNA probes
RNA probes were synthesized on a PCR template
generated using primers described in Supplementary
Table S1, and containing the T7 polymerase promoter
sequence.
Primer extension and RNase protection analyses
RNA was prepared from T. brucei cells using the
TRI-Reagent (Sigma). Primer extension analysis was per-
formed as described (33,34) using 50-end-labeled oligo-
nucleotides speciﬁc to each target RNA. The extension
products were analyzed on a 6% polyacrylamide/7M
urea gel and visualized by autoradiography. Total RNA
was prepared and analyzed by the RNase protection
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assay products were separated on 6% polyacrylamide/7M
urea gels and visualized by autoradiography. To calculate
differences in the level of extension products, the ﬁlms
were subjected to densitometric analysis using ImageJ.
AMT, in vivo UV cross-linking
Cross-linking was performed essentially as described in
(35). Brieﬂy, T. brucei cells were harvested at
1 10
7cells/ml and washed twice with PBS. Cells ( 10
9)
were concentrated and incubated on ice. 40-Aminomethyl–
trioxsalen hydrochloride (AMT) (Sigma) was added to the
cells at a concentration of 0.2mg/ml. Cells treated with
AMT were kept on ice and irradiated using a UV lamp
at 365nm at a light intensity of 10mW/cm
2 for 30min.
Next, the cells were washed once with PBS and
deproteinized by digestion with proteinase K (Roche)
(200mg/ml in 1% SDS for 60min). RNA was prepared
using TRI-Reagent (Sigma).
Afﬁnity puriﬁcation of snoRNAs using a complementary
20-O-methyl biotinylated oligonucleotides
First, 250mg of RNA extracted from UV treated cells
(+UV) and untreated cells (–UV), in hybridization
buffer (20mM HEPES pH 8, 5mM MgCl2, 300mM
KCl, 0.01% NP40, 1mM DTT) was heated for 2min at
80 C and then chilled on ice. Oligonucleotides linked to
biotin (Figure S1) (8mg) were added, and the solution was
incubated overnight at room temperature. Next, 50mlo f
blocked Neutravidin Sepharose beads (Pierce) were added,
and the reaction was incubated for 2h at 4 C. Blocking of
the beads was performed in 1ml blocking buffer [700ml
DEPC treated water, 200ml WB100 (20mM HEPES pH 8,
10mM MgCl2, 100mM KCl, 0.01% NP40 (v/v), 1mM
DTT), 50ml BSA (10mg/ml), 10ml Glycogen (20mg/ml),
40ml tRNA (11mg/ml)]. After binding of the RNA to the
oligonucleotide-bound beads, the beads were washed ﬁve
times in WB400 buffer [20mM HEPES pH 8, 10mM
MgCl2, 400mM KCl, 0.01% NP40(v/v), 1mM DTT].
RNA was eluted from the beads using the TRI-Reagent
(Sigma) and analyzed by primer extension (For
TB11Cs2C2) or by RT–PCR (for TB11Cs2C1).
RNaseH cleavage and splint labeling
RNase H cleavage of rRNA was performed by annealing
200pmol of oligonucleotides as indicated in the ﬁgures
(see Supplementary Figure S1 for speciﬁc primer se-
quences) with 20mg of total RNA at 65 C for 10min in
75mM KCl, 50mM Tris–HCl (pH 8.3), 3mM MgCl2,
10mM DTT. The samples were then placed on ice and
two units of RNase H (NEB) were added. The samples
were further incubated at 37 C for 60min, phenol/chloro-
form extracted, and ethanol precipitated. Samples were
then subjected to splint labeling. For splint labeling, the
RNA (10–20mg) was mixed with 150pmol of oligonucleo-
tide (see Supplementary Data S1 for primer sequence) and
heated for 2min at 85 C in 50mM Tris–HCl (pH 7.8),
10mM MgCl2 and 1mM DTT. The annealing reaction
was quenched on ice for 30min; 50mCi of [a-
32P]-dCTP
(3000Ci/mmol) and ﬁve units of T7 DNA polymerase
(Sequenase V. 2.0, USB) were then added, and the
reaction was incubated for 1h at 37 C. RNA was
separated on a 6% polyacrylamide–7M urea gel.
RT–PCR
The RNA was treated with the ‘DNase-free’ reagent
(Ambion) according to the manufacturer’s protocol for
30min to remove DNA contamination. Reverse transcrip-
tion was performed by random priming (Reverse tran-
scription system, Promega). The samples were heated for
5min at 70 C, followed by chilling on ice for 5min. Next,
one unit of AMV-reverse transcriptase (Promega) was
added, together with one unit RNase inhibitor
(Promega) and the elongation reaction was performed ac-
cording to the manufacturer’s instructions at 25 C for
10min and then at 42 C for 60min (Promega kit). The
cDNA was used for PCR ampliﬁcation using primers as
speciﬁed in Supplementary Table S1. The cDNA was
diluted to enable exponential ampliﬁcation by PCR as
determined by different dilutions of the cDNA. For
rRNA analysis, the cDNA was prepared from  1mg
RNA, and was diluted  1:500 for PCR ampliﬁcation.
To map the cross-linked adducts on rRNA, RNA
obtained from AMT-UV cross-linking (250mg) after
afﬁnity selection was used to prepare cDNA, and the
cDNA was diluted  1:50. PCR was performed on 1ml
of the diluted cDNA (described above), with the
addition of 1mM primers and ReadyMix
TMTaq PCR
Reaction Mix with MgCl2 (Sigma). The PCR conditions
were as follows: 95  for 2min, followed by 25 cycles of 95 
for 30s, 60  for 30s and 72  for 30s.
RESULTS
RNAi of TB11Cs2C2 snoRNA requires the nuclear Dicer,
TbDCL2, but not the cytoplasmic Dicer, TbDCL1
The snoRNA TB11Cs2C2 (92nt) is located in a cluster
that includes SLA1, which guides pseudouridylation on
the SL RNA (36,37), the snR30 homolog, which partici-
pates in rRNA processing (29), and another C/D snoRNA
species, TB11Cs2C1 (76nt). The C/D snoRNAs
TB11Cs2C1/C2 were implicated in guiding modiﬁcations
on rRNA by non-conventional guiding rules (30).
However, the methylation predicted to be modiﬁed by
TB11Cs2C1 (30) is guided by another snoRNA
(TB9Cs2C4) based on the conventional +5 rule that
governs the methylation of all trypanosome snoRNAs
(21,38). As opposed to the snoRNAs that guide modiﬁca-
tion, TB11Cs2C1/C2 are very abundant, like the U3
snoRNA (22). SnoRNAs are known to either guide modi-
ﬁcation, to function in rRNA processing, or to perform
both functions.
In this study, we utilized snoRNAi of TB11Cs2C2 as a
model both for elucidating the mechanism of snoRNAi
and to investigate the possible role of this RNA in
rRNA processing.
First, we examined which of the Dicers, TbDCL1
and/or TbDCL2, is essential for snoRNAi. The
TB11Cs2C2 gene was cloned into the pZJM vector,
7238 Nucleic Acids Research, 2010,Vol.38, No. 20expressing dsRNA from two T7 RNA pol opposing pro-
moters (31). The construct was used to transfect parental
cells, cells carrying a dominant negative TbDCL1 mutant
(3), and a cell line silenced for TbDCL2. The dominant-
negative TbDCL1 mutant was expressed as Tet-inducible
ectopic copy carrying a dual BB2/FLAG tag and a base
substitution of aspartate to glycine at amino acid 966 (3).
This mutant is defective in cytoplasmic RNAi triggered by
transfection of a-tubulin dsRNA, however its speciﬁc
mode of action has not been investigated further (3).
The results in Figure 1A–a demonstrate that, a cell line
carrying the silencing construct for TB11Cs2C2 expressed
the FLAG-tagged dominant-negative TbDCL1 upon
tetracycline induction. To examine the phenotype of
dominant-negative TbDCL1 and to verify that this
mutant is defective in cytoplasmic RNAi, two cell lines
were generated using the pZJM vector expressing
dsRNA to silence SmD3 from the two T7 opposing pro-
moters (31). One cell line contained the SmD3 silencing
construct, and the second cell line contained both the
SmD3 silencing construct as well as the dominant-negative
TbDCL1. The results (Figure 1A-b) demonstrate that the
presence of the dominant-negative TbDCL1 perturbed
the silencing of SmD3 (compare lanes 2–4). Next, the
TbDCL2 (Tb927.3.1230) was silenced by RNAi as
described in ‘Materials and methods’ section, using the
pZJM vector, described above (31). After establishing a
clonal cell population, we introduced the silencing
construct for TB11Cs2C2, carrying the blasticidin resist-
ance gene. The silencing of TbDCL2 was conﬁrmed
by northern analysis (Figure 1A-c), as well as
by demonstrating reduction in the level of CIR147
siRNAs (Figure 1A-d), whose production depends on
TbDCL2 (5).
After conﬁrming that silencing of TbDCL2 was efﬁ-
cient, the silencing of the TB11Cs2C2 snoRNA was
examined by primer extension. The results, shown in
Figure 1B and Supplementary Figure S2(A), quantitated
by densitometric analysis, demonstrate that induction of
TB11Cs2C2 silencing in parental cells reduced the level of
the snoRNA by 80% (compare lanes 1 and 2). Similarly,
the dominant-negative TbDCL1 mutant did not interfere
Figure 1. TbDCL2 but not TbDCL1 is essential for snoRNAi. (A) (a) Western blot analysis demonstrating the expression of DCL1-m carrying a
FLAG tag. A whole cell lysate was prepared from 10
8 cells and the blot was reacted with a monoclonal anti-ﬂag M2 antibody (Sigma). Equal loading
was conﬁrmed using anti-PTB antibodies (48). (b) Northern analysis of cells carrying the silencing constructs for SmD3 and TbDCl1-m. RNA was
prepared from uninduced cells (–Tet) and cells after 3 days of induction (+Tet). Total RNA (20mg/lane) was subjected to northern blot analysis with
random-labeled probes. The transcripts examined are indicated. Lanes 1 and 2, RNA was prepared from uninduced cells, or after induction, from
cells carrying the SmD3 silencing construct. Lanes 3, 4, the same as 1, 2 but from cells carrying both the silencing construct and the TbDCl1
mutation. The level of 7SL RNA was used to control for equal loading. (c) Northern analysis of cells carrying the silencing constructs for
TB11Cs2C2 and TbDCL2. Northern blot analysis of TbDCL2 mRNA after silencing. RNA was prepared from uninduced cells (–Tet) and cells
after 3 days of induction (+Tet). Total RNA (20mg/lane) was subjected to northern blot analysis with random-labeled probes. The transcripts
examined are indicated. The rRNA level was examined by ethidium bromide staining and was used as a control for loading. Hybridization with
rRNA probe was used and the sizes of mature and pre-rRNA were used as marker. (d) Northern analysis to determine the level of CIR147 under
TbDCL2 silencing. RNA was prepared from uninduced cells (–Tet), and cells after 3 days of induction (+Tet). The RNA was separated on a 10%
denaturing gel, and after electrotransfer, the membrane was hybridized with an RNA probe complementary to CIR147. pBR322 DNA-Msp I digest
was used as a size marker. The position of the siRNAs and the identity of the RNAs are indicated. (B) The level of TB11Cs2C2 snoRNA in
cells expressing the TbDCL1 dominant negative allele, and under TbDCL2 silencing. RNA was prepared from the different cell lines, before
induction (–Tet), and after induction (+Tet), and subjected to primer extension with oligonucleotide complementary to 30-end of TB11Cs2C2.
The products were separated on a 7M urea denaturing gel. Primer extension with anti-U3 speciﬁc probes was used to conﬁrm equal loading.
The identity of the RNAs and the cell lines are indicated. Lanes 1 and 2, RNA from parental cells carrying the silencing construct of TB11Cs2C2 (–
Tet), and after 3 days of induction (+Tet); lanes 3 and 4, the same as in lanes 1 and 2, but the cells carried the TbDCL1 mutant and the silencing
construct for TB11Cs2C2; lanes 5 and 6, as the previous lanes, but the cells carried the silencing construct for TB11Cs2C2 and a T7 RNA pol
opposing promoter construct to silence DCL2.
Nucleic Acids Research, 2010,Vol.38, No. 20 7239with snoRNAi, since the level of snoRNA was also
reduced by 85% upon tetracycline induction (compare
lanes 3 and 4). However, when snoRNAi was examined
under depletion of TbDCL2, only a minor reduction was
observed in the snoRNA level, suggesting that TbDCL2
but not TbDCL1 is essential for snoRNAi.
Argonaute is essential for snoRNAi
To examine if, as in cytoplasmic RNAi, both Dicer and
Argonaute are necessary to execute the silencing, the effect
of TbAGO1 silencing on snoRNAi was examined.
TbAGO1 was silenced using a T7 RNA pol opposing con-
struct (31). Cell lines silenced for TbAGO1 were then
transfected with the silencing construct for TB11Cs2C2,
and a stable clonal cell line was established and further
characterized. The western blot analysis presented in
Figure 2A indicated that the TbAGO1 level was signiﬁ-
cantly reduced in this cell line, suggesting the efﬁcient
silencing of TbAGO1 in cells expressing the silencing con-
structs for both TbAGO1 and TB11Cs2C2. Next, the level
of the snoRNA was examined by primer extension in the
different cell lines. The results, shown in Figure 2B (lanes 1
and 2) and Supplementary Figure S2(B), demonstrate that
silencing of snoRNA is compromised in cells silenced for
TbAGO1. As a control, silencing of TB11Cs2C2 in the
parental strain was examined (lanes 3 and 4). Thus, the
results shown in Figures 1 and 2 suggest that snoRNAi
requires both TbAGO1 and TbDCL2.
TB11Cs2C2 is a snoRNA that interacts by base-pairing
with srRNA-2 and srRNA-6
As mentioned above, several ﬁndings suggest that
TB11Cs2C2 is likely to have a special function in rRNA
processing: it is located in a cluster whose members are
abundant RNAs with functions other than rRNA modiﬁ-
cation; it is not involved in methylation, as was initially
proposed (30); and it is as abundant as U3 snRNP, which
functions in rRNA processing (22).
To elucidate the function of this snoRNA, a bioinfor-
matic search was conducted to identify potential targets.
The entire rRNA cluster (GenBank AL929603.2) was
analyzed by BLAST to identify potential base-pair inter-
actions between the snoRNA and rRNA. Four potential
base-pair interaction domains with rRNA were found;
two sites with extensive complementarity between
TB11Cs2C2 and the coding region of srRNA-2 and -6
(see Figure 4A for a schematic representation of the
rRNA locus) and two weak interactions in ITS6 and
ITS7 (not presented). The potential interactions between
TB11Cs2C2 and srRNA-2 and -6 are depicted in
Figure 3A and B. Based on this model, different
domains of TB11Cs2C2 are involved in base-pair inter-
action with each of the targets. The secondary structure
of TB11Cs2C2 is in agreement with the canonical struc-
ture of C/D snoRNA (20). In addition, a stem-loop struc-
ture is situated upstream to the interaction domain with
srRNA-6. The validity of this structure is supported by
phylogenic conservation among the trypanosomes
(T. brucei, T. vivax and T. cruzi). Sequence differences
that exist among the trypanosomatids include compensa-
tory changes that maintain both the structure of the stems
as well as the predicted base-pairing with the rRNA
targets (Figure 3A).
To obtain biochemical evidence for these interactions,
we carried out AMT treatment followed by UV
cross-linking. AMT compounds are unique in their
ability to freeze helical regions of nucleic acids. First, the
planar AMT molecule intercalates within the
double-helical region; upon irradiation at 365nm,
covalent adducts with pyrimidine bases are formed (39).
This method was used previously in trypanosomes to
identify interactions between the spliced leader RNA
and other small RNA species (35,40). AMT intercalates
within stems formed either inter- or intra-molecularly. To
identify intermolecular interactions, a protocol was
devised to enrich the cross-linked adducts by afﬁnity se-
lection using an anti-sense biotinylated oligonucleotide
complementary to TB11Cs2C2. After afﬁnity selection,
the adducts were mapped on TB11Cs2C2 by primer ex-
tension (note that reverse transcriptase usually stops one
nucleotide before the cross-linked site). Only adducts that
were enriched by the afﬁnity selection were considered to
have resulted from the interaction between TB11Cs2C2
and rRNA. To evaluate intramolecular cross-links, total
RNA was extracted from AMT-treated cross-linked cells,
separated on a denaturing gel, and the RNA band corres-
ponding to the size of TB11Cs2C2 was excised and used to
map the cross-linked adducts. This RNA should only
contain intramolecular cross-linked adducts but not inter-
molecular cross-linked sites. Thus, primer extension stops
common to lanes 4 and lane 6 in Figure 3C are the result
of intramolecular cross-linking. These stops are marked
with white arrowheads (Figure 3C) and are circled on
the secondary structure diagram, and ﬁlled in gray
(Figure 3A). The adducts were mapped to the proposed
stems, supporting the proposed secondary structure of the
molecule. In the unique stem located between positions
21 and 49nt of the RNA, four intermolecular cross-linked
adducts were detected (U24, U34, U41, U47) and a single
Figure 2. AGO1 is essential for snoRNAi. (A) Western blot analysis
demonstrating the depletion of AGO1. A whole-cell lysate was
prepared from 10
8 cells, and the blot was reacted with anti-AGO1
antibodies. Equal loading was conﬁrmed by reactivity with anti-PTB1
antibodies. (B) Primer extension demonstrating the dependence of
snoRNAi on TbAGO1. RNA was prepared before silencing (–Tet) or
after 3 days of silencing (+Tet), and was examined by primer extension.
Primer extension of U3 snoRNA was used to control for equal loading.
The identities of the RNA species and the cell lines are indicated. Lanes
1 and 2, RNA from cells expressing both the silencing construct for
AGO1 and TB11Cs2C2 before and after 3 days of induction; lanes 3
and 4, the same as in lanes 1 and 2, but the cells carried the silencing
construct for TB11Cs2C2.
7240 Nucleic Acids Research, 2010,Vol.38, No. 20adduct (U9) was revealed in the terminal stem. An adduct
was also mapped at position U16, in a single stranded
domain, suggesting a possible tertiary intramolecular
interaction. Interestingly, a stop corresponding to
position 53 (marked with a black arrowhead) was also
observed (Figure 3C). This stop was not found in RNA
extracted from the gel, but was only enriched in RNA
puriﬁed by afﬁnity-selection, suggesting that this stop rep-
resents an intermolecular cross-link and not an intramo-
lecular one. This cross-linked position lies exactly in the
Figure 3. Potential interactions of TB11Cs2C2 snoRNA with rRNA. (A) The predicted secondary structure of TB11Cs2C2. The structure is pre-
sented showing potential interactions with small rRNA-2 and -6. The intramolecular cross-linked sites are circled and ﬁlled in gray, and the
intermolecular site is boxed. Changes in the sequence compared to T. brucei are circled; green and turquoise represent T. cruzi and T. vivax,
respectively. The yellow circles indicate changes in T. brucei between the sequence in the different repeats. (B) Potential base-pair interaction between
srRNA and TB11Cs2C2. (a) interaction with srRNA-6; and (b) interaction with srRNA-2. The positions on both RNAs are indicated; the intra-
molecular cross-linked adducts are boxed. (C) Primer extension to map the AMT-adducts on TB11Cs2C2. Cells (10
10) were treated with AMT and
irradiated with UV light at 365nm with an intensity of 10mW/cm
2 for 60min. RNA was prepared from irradiated cells and from control untreated
cells and subjected to afﬁnity selection using a 20-O-methyl biotinylated oligonucleotide complementary to TB11Cs2C2. RNA from the different
samples was subjected to primer extension with a primer complementary to TB11Cs2C2. Lanes 1, 3, 5: RNA was derived from the same step of
puriﬁcation but was extracted from untreated control cells. Lane 2, total RNA (10mg) from treated cells. Lane 4, afﬁnity selected RNA prepared as
speciﬁed in ‘Materials and Methods’ section. Lane 6, RNA ( 90nt) from cells treated with AMT and subjected to UV cross-linking eluted from a
preparative gel as described in ‘Materials and Methods’ section. The extension products were separated on a 6% denaturing gel. The different
treatments are indicated above the lanes. DNA sequencing of the clone carrying the TB11Cs2C2 gene with the same primer was used for mapping the
adducts, and is given in the opposite orientation to correspond with the coding sequence of the RNA, indicated on the left. The white arrows indicate
stops due to intramolecular cross-linking, and the black arrow indicates the stop due to an intermolecular cross-linked adduct. The identity of the U
residue downstream from the cross-linked site is indicated. (D) RNaseH mapping of TB11Cs2C2 cross-linked species. (a) Cross-linking to srRNA-6.
RNA from untreated cells (lane 1), after cross-linking (lane 2), after cross-linking but digested with RNaseH (lane 3). The RNA was digested with
RNaseH in the presence of oligonucleotide prior to splint labeling. The RNA was subjected to splint labeling, and the products were separated on a
6% denaturing gel next to the pBR322 DNA-Msp I digest. The location of oligonucleotide binding and the distance between the cleavage site is
given. (b) The same as in a but the analysis was performed using an oligonucleotide situated within srRNA-2.
Nucleic Acids Research, 2010,Vol.38, No. 20 7241intermolecular duplex between TB11Cs2C2 and srRNA-6,
depicted in Figure 3A. Note that an additional weak stop
was observed one nt after the major stop, which results
from reverse transcriptase stopping at the cross-linked site
itself.
To gain further support for the proposed interaction
between TB11Cs2C2 and its two targets, the cross-linked
species between the snoRNA and rRNA were analyzed by
RNaseH mapping. The snoRNA-associated rRNA species
were tagged by the splint labeling technique. In this
method, a primer complementary to TB11Cs2C2
carrying a run of 8G nt at the 30-end of the oligonucleo-
tide was used as template to incorporate [a-
32P]-dCTP at
the 30-end of TB11Cs2C2 using the enzyme T7 DNA poly-
merase (Supplementary Figure S1). In such an experiment,
we anticipate identifying cross-links between TB11Cs2C2
and the different rRNA species linked to it. Indeed, upon
UV cross-linking and splint labeling, a major cross-linked
species appeared at the top of the gel [Figure 3D (a and b),
lanes 2]. To map the cross-linked adducts, the rRNA was
ﬁrst speciﬁcally digested by RNaseH and speciﬁc oligo-
nucleotides to rRNA and pre-rRNA (depicted schematic-
ally in Figure 3D). After digestion, the digested fragments
carrying TB11Cs2C2, were detected by splint-labeling
using the snoRNA-speciﬁc oligonucleotide. The results
in Figure 3D–a demonstrate that upon RNaseH
cleavage, the level of cross-linked species migrating at
the top of gel was reduced and two new species of sizes
 130 and 170nt appeared. The  130-nt fragment [marked
as (1)] was most probably generated by cleavage of a
species that was cross-linked to the srRNA-6 before pro-
cessing, and was then processed by cleaving at the 30-end
of the srRNA-6. The  170-nt fragment is most probably
the result of cleavages at both the internal oligonucleotide
as well as the oligonucleotide situated at ITS7 [marked as
(2)]. The size on gel represents the size of the rRNA
fragment and the size of cross-linked TB11Cs2C2. These
data support the interaction of TB11Cs2C2 with
srRNA-6. Validating the interaction of TB11Cs2C2 with
srRNA-2 was even more important, since it is impossible
to detect such interaction by primer extension because the
interaction domain lies at the 30-end of the snoRNA. The
same methodology described in panel a, was used to dem-
onstrate the association with srRNA-2. Upon cleavage,
two species of 140nt were detected by using an oligo-
nucleotide situated within the srRNA-2 (Figure 3D-b).
These species are most probably generated from
cleavage of the mature srRNA-2 carrying the cross-linked
molecules. The heterogeneity in size of the fragments may
stem from heterogeneity at the 50-end of srRNA-2.
The data presented in panel D support the interaction
of TB11Cs2C2 with both rRNA targets. It is not known if
these interactions take place simultaneously or
sequentially.
snoRNAi suggests that TB11Cs2C2 snoRNA functions
in processing of small rRNAs within the LSU
rRNA coding region
Based on the putative interaction domain between
TB11Cs2C2 and rRNA (Figure 3A and B), we examined
if this RNA is involved in rRNA processing. To this end,
the cell line carrying the silencing construct for
TB11Cs2C2 was used. To identify rRNA processing
defects that might exist in these cells, RT–PCR and
RNase protection assays were performed. Cells silenced
for NOP58 were used as a control to calibrate the
defects in rRNA processing. NOP58 is a structural
protein that binds to all C/D snoRNAs and is essential
for the stability of the particles. We previously reported
the silencing of this factor (22). Total RNA was prepared
from uninduced cells and NOP58 silenced cells after 3days
of silencing. The levels of the precursors, internal
transcribed spacer (ITS) or external transcribed spacer
(ETS) of rRNA (schematically represented in
Figure 4A), were measured by RT–PCR. The results
(Figure 4B-a) demonstrate the accumulation of precursors
for all the intergenic regions under conditions of NOP58
silencing, suggesting the C/D snoRNA family must par-
ticipate in processing SSU, LSUa and LSUb rRNA, but
also in the cleavage of srRNAs. The same RT–PCR meth-
odology was used to examine the defects in cells silenced
for TB11Cs2C2. The results (Figure 4B-b) demonstrate
increase in ITS5 and ITS7 levels in TB11Cs2C2-silenced
cells. No other major changes were observed in the other
ITS’s, suggesting the TB11Cs2C2 functions in processing
events required to release srRNA-2 and -6. Next, an
RNase protection assay was used to examine the level of
srRNAs and their precursors. Anti-sense RNA probes
were synthesized to the different domains as depicted in
Figure 4C, and the protected fragments of mature RNA
and the precursor were examined in uninduced cells and
after 3 days of silencing (Figure 4C). The results demon-
strate major changes in the level of ITS5 and ITS7 precur-
sors (boxed) accompanied by clear reduction in the level of
LSUb and srRNA-6 (boxed) rRNAs. No change in pre-
cursors was observed for ITS6, suggesting that
TB11Cs2C2 most probably mediates the processing
upstream of srRNA-2 and downstream of srRNA-6.
These processing events therefore release srRNA-2 and -
6 from the precursor. These results are in agreement with
the bioinformatic predictions and AMT-UV cross-linking
(Figure 3).
TB11Cs2C1 snoRNA may function in processing
of SSU rRNA
TB11Cs2C1 is located between snR30 and TB11Cs2C2 in
the same locus, as described above. This snoRNA is also
very abundant (22). As stated above, this snoRNA is not
involved in modiﬁcation. To examine if TB11Cs2C1 may
function in rRNA processing, a bioinformatic search
described above was performed, to examine the potential
interaction of this snoRNA with rRNA. The results,
shown in Figure 5A and B, demonstrate two potential
base-pair interactions; one within rRNA, as previously
suggested (30), and one in the ETS close to the A0
cleavage site. To examine if these interactions take place
in vivo, these potential associations were examined
by AMT UV cross-linking, as described above. The
RNA was subjected to afﬁnity selection using an anti-
sense biotinylated oligonucleotide complementary to
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rRNA domain, using RNA extracted from UV irradiated
cells and afﬁnity selected with the snoRNA anti-sense
oligonucleotide, indicated a cross-linked adduct on SSU
rRNA at position U1900, further supporting the inter-
action between TB11Cs2C1 and SSU rRNA. The speciﬁ-
city of the cross-linking is evident, since the stop was
eliminated following irradiation at 254nm, which
photoreversed the cross-linking (Figure 5C).
To evaluate the interaction with the ETS and
TB11Cs2C1, we used the ‘RNA walk’ methodology that
was recently developed in our group (41). The method is
based on UV induced AMT cross-linking in vivo followed
by afﬁnity-selection of the hybrid molecules and mapping
the intermolecular adducts by RT–PCR or real-time PCR.
Domains carrying cross-linked adducts fail to efﬁciently
amplify by PCR as compared with non-cross linked
domains. To this end, RNA was prepared from the
Figure 4. Functional analysis of TB11Cs2C2 snoRNA by RNAi. (A) Schematic representation of the pre-rRNA. The coding sequences are shown in
black. The identity of the intergenic regions is given and the position of the cleavages is indicated. The proposed interaction domains of TB11Cs2C1
and C2 based on this study, are indicated. (B) RT–PCR comparing the rRNA processing defects under NOP58 silencing and TB11Cs2C2 silencing.
RNA from uninduced cells or cells after 3 days of induction was used to prepare cDNA. cDNA was ampliﬁed with primers situated in the intergenic
regions speciﬁed in Supplementary Data S1. The level of nucleoside transporter (TbNT) was used to normalize the level of RNA in each sample. The
identity of the intergenic regions is indicated. (a) cDNA was taken from a cell line expressing the NOP58 silencing construct; (b) cDNA was prepared
from cells expressing the TB11Cs2C2 silencing construct. The fold increase in the level of the intergenic region precursor is given below each panel.
(C) RNase protection to detect accumulation of precursor, and reduction of mature rRNA. RNA from cells expressing the TB11Cs2C2 was used for
RNase protection assay. The products were separated on a 6% denaturing gel. The structure of the anti-sense probe is schematically presented.
The precursor and the mature snoRNAs are boxed. The sizes of the molecular weight marker (pBR322 DNA-MspI digest) are indicated. In each
panel: Lane 1, probe; lane 2, protection assay in the absence of RNA; lane 3, RNA from uninduced cells; lane 4, RNA from cells after 3 days of
induction.
Nucleic Acids Research, 2010,Vol.38, No. 20 7243Figure 5. Potential interactions of TB11Cs2C2 snoRNA with rRNA. (A) The secondary structure of TB11Cs2C1. The base-pair interactions with the
SSU rRNA and 50-ETS sequences are presented. (B) Base-pair interaction between Tb11Cs2C1 and the target. The potential intermolecular
cross-linked positions are circled. (C) Primer extension to map AMT adducts between TB11Cs2C1 and SSU rRNA. RNA from the afﬁnity
selected sample prepared from untreated cells or after AMT and UV cross-linking was taken for primer extension using a primer speciﬁed in
Supplementary Figure S1. The extension was examined next to the DNA sequence of SSU rRNA in this domain. The sequence represents the RNA
sequence (complementary to the cDNA synthesized). Cross linking was photoreversed by irradiation at 254nm for 30min, and the RNA was
subjected to primer extension. To control for equal loading, a structural stop at a different position was compared. (D) Mapping the interaction
domain of TB11Cs2C1 with 50-ETS. (a) Schematic representation of the ETS domain. The positions of the primers used for ampliﬁcation are
indicated. X denotes the cross-linked position. (b) RT–PCR along the 50-ETS. cDNA was prepared from the afﬁnity selected RNA of untreated cells
or after treatment with AMT and UV cross-linking. The cDNA was subjected to PCR using the set of primers indicated in panel a, and the PCR
products were separated on a 1% agarose gel and stained with ethidium bromide. (E) Primer extension to map the AMT adducts on TB11Cs2C1.
RNA derived from afﬁnity selection of untreated cells (–UV) or after AMT and UV cross-linking, was extended with oligonucleotide complementary
to the 30-end of TB11Cs2C1. The products were separated on a 6% denaturing gel next to the DNA sequence of TB11Cs2C1 using the same primer.
The sequence of this region is indicated.
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oligonucleotide to TB11Cs2C1. Following cDNA prepar-
ation using random primers, PCR was performed on the
cDNA using three pairs of primers, as indicated in
Figure 5D-a. The results in Figure 5D-b demonstrate
that all domains were ampliﬁed from cDNA prepared
from control cells. However, the fragment carrying the
potential cross-linked domain could not be ampliﬁed
when cDNA from the AMT UV cross-linking preparation
was used, suggesting that this domain is cross-linked to
rRNA. Interestingly, the other domains located on
the pre-rRNA were more efﬁciently ampliﬁed
after AMT-UV cross-linking and afﬁnity selection
(Figure 5D-b, compare lanes 2 and 4 with 1 and 3),
since pre-rRNA is enriched by the afﬁnity-selection
procedure.
To verify that TB11Cs2C1 is indeed cross-linked at the
relevant positions involved in interactions with the two
targets, the afﬁnity-selected RNA was used in primer ex-
tension with primer speciﬁc to TB11Cs2C1. The results
suggest that primer extension stops were only observed
in the afﬁnity selected RNA at positions located within
the TB11Cs2C1-rRNA interaction domains (Figure 5A
and B). The adduct due to interaction with U22 results
from cross-linking to SSU rRNA, whereas the adducts on
U32 and U35 most probably result from interaction with
the 50-ETS. These data suggest that TB11Cs2C1 interacts
with both SSU rRNA and pre-rRNA (50-ETS), and there-
fore is most probably involved in SSU rRNA processing.
The ultimate proof of the involvement of this snoRNA in
rRNA processing could have been obtained by snoRNAi.
However, we failed to obtain >45% reduction in the level
of snoRNA in the silenced cells, and as a result of the
inefﬁcient knock-down, rRNA processing defects could
not be detected. Only two kinds of snoRNAs exist,
those that guide methylation and/or those that are
involved in rRNA processing. The methylation that
exists in the interaction domain of TB11Cs2C1 and
SSU, is not guided by TB11Cs2C1 as previously shown
(30), but is guided by TB9Cs2C4 (21) according to the+5
rule. This strongly suggests that TB11Cs2C1 is involved in
rRNA processing of SSU.
DISCUSSION
In this study, the mechanism of snoRNAi was elucidated
and was found to require both TbAGO1 (Slicer) and
TbDCL2 (Dicer). The dependence on TbDCL2 for
snoRNAi stems from the localization of the target in the
nucleolus.
The data obtained in this study are in agreement with a
very recent study showing that the accumulation of tran-
scripts from the CIR147 repeats in T. brucei is only
slightly affected by TbDCL1 knock-out, but requires
TbDCL2 activity (5). These repeats generate bona ﬁde
siRNAs harboring a 50 monophosphate and a modiﬁed
30-end (5). Like snoRNAs, CIR147 RNAs never leave
the nucleus, and therefore their silencing depends on the
nuclear Dicer isoform. It is possible that dsRNA produced
by T7 RNA pol opposing constructs in the transgenic cells
expressing the silencing construct for TB11Cs2C2 are
transported to the cytoplasm and are digested to
siRNAs by TbDCL1. However, due to the absence of
the target in the cytoplasm, these siRNAs would not be
effective silencers. In order to mediate snoRNAi, siRNAs
must be in the nucleus and interact with both AGO1 and
the target snoRNA. Interestingly, in ago1
 /– cells, CIR147
transcripts accumulate in the nucleolus, raising the
intriguing possibility that silencing may take place in
this compartment (8). The presence of the RNAi machin-
ery in the nucleolus may explain why snoRNAi is so
efﬁcient.
It is currently unknown if snoRNAi has a physiological
role, or if this mechanism simply takes advantage of the
machinery that exists in the nucleus/nucleolus for silencing
retroposons and the CIR147 transcripts (5). However,
since we know so little about how snoRNAs are regulated
and processed in the cells, it is still possible that snoRNAi
has a physiological role in these processes. Interestingly,
silencing of two small nuclear RNAs, namely telomerase
RNA and 7SK RNA, was reported in mammalian cells
using siRNAs. This suggests that DICER and AGO2
must also operate in the nucleus of mammalian cells to
execute similar silencing (12).
This study also sheds light on the complex processing of
rRNA in trypanosomes (Figure 4A). The cleavages that
excise the SSU rRNA are different in trypanosomes as
compared to other eukaryotes such as yeast and
mammals (42). In trypanosomes, the ﬁrst cleavage is
between the SSU rRNA and 5.8S RNA at position B1,
and only later do cleavages occur at positions A0, A0, A1
and A2 (43). In yeast and mammals, the cleavages to
release the SSU rRNA ﬁrst take place at A1 and A0,
and only later do cleavages separate the SSU rRNA
from 5.8S RNA (42). So far, only the U3 snoRNA was
implicated in processing rRNA in the 50-ETS domain of
trypanosome rRNA (44,45). Another RNA that is
implicated in processing of SSU rRNA is snR30, and
this RNA was identiﬁed in the locus that also contains
TB11Cs2C1 and TB11Cs2C2, described in this study
(29). There are two additional snoRNAs that were
shown to release the SSU rRNA in other eukaryotes,
U14 (46) and U22 (47). Our bioinformatic searches
failed to identify U14 and U22 homologs among the
snoRNAs identiﬁed so far. TB11Cs2C1 has the potential
to function in SSU rRNA processing, since it interacts
with SSU rRNA at the 30-end of the RNA as well as at
a position upstream to A0. Although there is no structural
resemblance between TB11Cs2C1 and U14, TB11Cs2C1
may nevertheless function as the functional trypanosome
homolog of U14.
Interestingly, recent deep-sequencing analysis of small
RNPs in T. brucei (Ullu and Michaeli unpublished results)
identiﬁed highly abundant C/D molecules; these candi-
dates most probably include previously unidentiﬁed
snoRNA and/or snoRNA that carry out trypanosome-
speciﬁc processing events. Work is in progress, using
snoRNAi, to examine the distinct roles of these
snoRNAs in rRNA processing.
The ﬁrst snoRNA found to be involved in srRNA pro-
cessing, TB11Cs2C2, was analyzed in this study. This
Nucleic Acids Research, 2010,Vol.38, No. 20 7245RNA has the potential to interact with both srRNA-2 and
-6, and AMT-UV cross-linking performed in this study
conﬁrmed these interactions. The defects observed in
rRNA processing suggest that this snoRNA may direct
the cleavage upstream from srRNA-2 and downstream
from srRNA-6. Interestingly, we did not observe accumu-
lation of ITS6, located between srRNA-2 and srRNA-6,
suggesting that there must be another snoRNA that
mediates the cleavage of srRNA-2 from the precursor.
Indeed, when the rRNA defects were examined in cells
depleted for H/ACA RNAs via CBF5 silencing (29), a
signiﬁcant accumulation of ITS6 was observed, suggesting
that there must exist an H/ACA RNA that is involved in
trypanosome-speciﬁc rRNA processing at this site.
In summary, snoRNAi reﬂects the activity of the
nuclear silencing machinery of trypanosomes, which
most probably evolved to silence repeats and retroposons,
but may have additional novel functions that have not
been identiﬁed to date. However, snoRNAi can be
utilized experimentally for functional analysis of nuclear/
nucleolar ncRNAs. This study highlights the function of
two abundant trypanosome snoRNPs, TB11Cs2C2, which
functions in srRNA processing, and TB11Cs2C1, which is
implicated in SSU rRNA processing, since it is no longer
believed to function in rRNA methylation. TB11Cs2C1
may represent a functional homolog of snoRNA(s)
found in other eukaryotes, which process rRNA at
similar sites. The use of snoRNAi, together with
deep-sequencing data, is expected to help identify add-
itional trypanosome-speciﬁc snoRNAs in the near future.
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